The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
Open accessAbstract
Injury or impaired clearance of apoptotic cells leads to the pathological accumulation of necrotic corpses, which induce an inflammatory response that initiates tissue repair. In addition, antigens present in necrotic cells can sometimes provoke a specific immune response and it has been argued that necrosis could explain adaptive immunity in seemingly infection-free situations, such as after allograft transplantation or in spontaneous and therapy-induced tumour rejection. In the mouse, the CD8alpha+ subset of dendritic cells phagocytoses dead cell remnants and cross-primes CD8+ T cells against cell-associated antigens. Here we show that CD8alpha+ dendritic cells use CLEC9A (also known as DNGR-1), a recently-characterized C-type lectin, to recognize a preformed signal that is exposed on necrotic cells. Loss or blockade of CLEC9A does not impair the uptake of necrotic cell material by CD8+ dendritic cells, but specifically reduces cross-presentation of dead-cell-associated antigens in vitro and decreases the immunogenicity of necrotic cells in vivo. The function of CLEC9A requires a key tyrosine residue in its intracellular tail that allows the recruitment and activation of the tyrosine kinase SYK, which is also essential for cross-presentation of dead-cell-associated antigens. Thus, CLEC9A functions as a SYK-coupled C-type lectin receptor to mediate sensing of necrosis by the principal dendritic-cell subset involved in regulating cross-priming to cell-associated antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of caspases, a specific class of cysteine proteases has multiple effects on the immunogenicity of cell death 56”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Necrosis has traditionally been considered merely as an accidental, uncontrolled form of cell death that only occurs in pathological circumstances.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“There are several distinct subtypes of apoptosis that, although morphologically similar, can be triggered through different biochemical routes (for example, through the intrinsic or the extrinsic pathway or with or without caspase activation).”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Necrosis is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Autophagic cell death occurs in the absence of chromatin condensation but is accompanied by massive autophagic vacuolization of the cytoplasm.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Apoptosis is accompanied by rounding-up of the cell, retraction of pseudopods, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), few or no ultrastructural modifications of cytoplasmic organelles, and plasma membrane blebbing but cell integrity is maintained until the final stages of the process.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Furthermore, the apparent uniformity of apoptotic cell death may conceal heterogeneous functional aspects, such as whether or not dying apoptotic cells are recognized by the immune system 56.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“CLeC9A has been shown to recognize necrotic cells and induce the cross-presentation of dead cell-associated antigens to CD8+ T cells.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [75]
In the citing paper
“Therefore, it may be involved in regulating sterile immune responses, although the specific ligand recognized in this case is still unknown73,75.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M. P., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,601
Brown, G. D., & Gordon, S. (2001) · Nature · doi:10.1038/35092620 · Cited by 1,579
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Sauter, B., Albert, M. L., Francisco, L. M., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,357
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 750
Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss
Maremonti, F., Meyer, C., & Linkermann, A. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021101293 · Cited by 213
Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense
Leiva‐Juárez, M. M., Kolls, J. K., & Evans, S. E. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.71 · Cited by 204
Neumann, K., Castiñeiras-Vilariño, M., Höckendorf, U., Hannesschläger, N., Lemeer, S., Kupka, D., Meyermann, S., Lech, M., Anders, H., Küster, B., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.015 · Cited by 202
Human dendritic cell subsets and function in health and disease
O’Keeffe, M. A., Mok, W. H., & Radford, K. J. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2005-0 · Cited by 203
C-Type Lectin-Like Receptors of the Dectin-1 Cluster: Ligands and Signaling Pathways
Plato, A., Willment, J. A., & Brown, G. D. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.777065 · Cited by 212
Paclitaxel Induces Immunogenic Cell Death in Ovarian Cancer via TLR4/IKK2/SNARE-Dependent Exocytosis
Lau, T., Chan, L. K. Y., Man, G. C. W., Wong, C. H., Lee, J. H. S., Yim, S. F., Cheung, T. H., McNeish, I. A., & Kwong, J. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0616 · Cited by 200
Are Conventional Type 1 Dendritic Cells Critical for Protective Antitumor Immunity and How?
Cancel, J.-C., Crozat, K., Dalod, M., & Mattiuz, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00009 · Cited by 198
Chemotherapy and radiotherapy: Cryptic anticancer vaccines
Ma, Y., Kepp, O., Ghiringhelli, F., Apétoh, L., Aymeric, L., Locher, C., Tesnière, A., Martins, I., Ly, A., Haynes, N. M., et al. (2010) · Seminars in Immunology · doi:10.1016/j.smim.2010.03.001 · Cited by 198
Regulation of the Cell Biology of Antigen Cross-Presentation
Blander, J. M. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055523 · Cited by 206
Personalized Dendritic Cell Vaccines‐Recent Breakthroughs and Encouraging Clinical Results
Mastelic-Gavillet, B., Balint, K., Boudousquie, C., Gannon, P. O., & Kandalaft, L. E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00766 · Cited by 189
Human skin dendritic cells in health and disease
Haniffa, M., Gunawan, M., & Jardine, L. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2014.08.012 · Cited by 187
Dying cell clearance and its impact on the outcome of tumor radiotherapy
Lauber, K., Ernst, A., Orth, M., i, M. H., & Belka, C. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00116 · Cited by 200
Crozat, K., Guiton, R., Guilliams, M., Henri, S., Baranek, T., Schwartz-Cornil, I., MALISSEN, B., & Dalod, M. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00868.x · Cited by 185
Canton, J., Blees, H., Henry, C. M., Buck, M. D., Schulz, O., Rogers, N. C., Childs, E., Zelenay, S., Rhys, H. I., Domart, M., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-00824-x · Cited by 197
Self-citationDendritic Cells Limit Fibroinflammatory Injury in Nonalcoholic Steatohepatitis in Mice
Henning, J. R., Graffeo, C. S., Rehman, A., Fallon, N. C., Zambirinis, C. P., Ochi, A., Barilla, R., Jamal, M., Deutsch, M., Greco, S., et al. (2013) · Hepatology · doi:10.1002/hep.26267 · Cited by 185
Necroptosis: an alternative cell death program defending against cancer
Chen, D., Yu, J., & Zhang, L. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.03.003 · Cited by 192
Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
Macri, C., Dumont, C., Johnston, A. P. R., & Mintern, J. D. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.6 · Cited by 187
MacNabb, B. W., Chen, X., Tumuluru, S., Godfrey, J. K., Kasal, D. N., Yu, J., Jongsma, M. L. M., Spaapen, R. M., Kline, D. E., & Kline, J. P. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.016 · Cited by 189
Ontogeny and Functional Specialization of Dendritic Cells in Human and Mouse
Haniffa, M. A., Collin, M. P., & Ginhoux, F. (2013) · Advances in immunology · doi:10.1016/b978-0-12-417028-5.00001-6 · Cited by 199
Chemical Allergy: Translating Biology into Hazard Characterization
Kimber, I., Basketter, D. A., Gerberick, G. F., Ryan, C. A., & Dearman, R. J. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq346 · Cited by 184
Cross-presentation of cell-associated antigens by MHC class I in dendritic cell subsets
Gutiérrez-Martínez, E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00363 · Cited by 191
The cytoskeleton in cell-autonomous immunity: structural determinants of host defence
Mostowy, S., & Shenoy, A. R. (2015) · Nature reviews. Immunology · doi:10.1038/nri3877 · Cited by 190
Functional Roles of Syk in Macrophage-Mediated Inflammatory Responses
Yi, Y.-S., Son, Y.-J., Ryou, C., Sung, G.-H., Kim, J.-H., & Cho, J. (2014) · Mediators of Inflammation · doi:10.1155/2014/270302 · Cited by 172
The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice
Iborra, S., Izquierdo, H. M., Martínez‐López, M., Blanco-Menéndez, N., Sousa, C. R. E., & Sancho, D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60660 · Cited by 175
Self-citationDendritic cell maturation in cancer
Moon, C. Y., Belabed, M., Park, M. D., Mattiuz, R., Puleston, D. J., & Mérad, M. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00787-3 · Cited by 189
Teichmann, L. L., Ols, M. L., Kashgarian, M. J., Reizis, B., Kaplan, D. H., & Shlomchik, M. J. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.025 · Cited by 178
Necroptosis in Immuno-Oncology and Cancer Immunotherapy
Sprooten, J., Wijngaert, P. D., Vanmeerbeek, I., Martin, S., Vangheluwe, P., Schlenner, S., Krysko, D. V., Parys, J. B., Bultynck, G., Vandenabeele, P., et al. (2020) · Cells · doi:10.3390/cells9081823 · Cited by 173
Syk-coupled C-type lectins in immunity
Kerrigan, A. M., & Brown, G. D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.01.002 · Cited by 170
Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response
Schiavoni, G., Mattei, F., & Gabriele, L. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00483 · Cited by 176
Discovering dominant tumor immune archetypes in a pan-cancer census
Combes, A. J., Samad, B., Tsui, J. L., Chew, N. W., Yan, P., Reeder, G. C., Kushnoor, D., Shen, A. S., Davidson, B. R., Barczak, A. J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.12.004 · Cited by 170
Organization of the mouse and human DC network
Schlitzer, A., & Ginhoux, F. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.11.002 · Cited by 167
Bredholt, G., Mannelqvist, M., Stefansson, I. M., Birkeland, E., Bø, T. H., Oyan, A. M., Trovik, J., Kalland, K., Jonassen, I., Salvesen, H. B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5344 · Cited by 168
Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry
Plüddemann, A., Mukhopadhyay, S., & Gordon, S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00989.x · Cited by 170
Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state
Cerezo‐Wallis, D., Contreras-Alcalde, M., Troulé, K., Catena, X., Mucientes, C., Calvo, T. G., Cañón, E., Tejedo, C., Pennacchi, P. C., Hogan, S. A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1073-3 · Cited by 168
Rosen, R., Gupta, A. K., & Tyring, S. K. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.038 · Cited by 161
Kerrigan, A. M., & Brown, G. D. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00882.x · Cited by 167
Natural and Induced Tolerogenic Dendritic Cells
Iberg, C. A., & Hawiger, D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901121 · Cited by 166
Eat-Me: Autophagy, Phagocytosis, and Reactive Oxygen Species Signaling
Vernon, P. J., & Tang, D. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4810 · Cited by 161
Akalu, Y. T., Rothlin, C. V., & Ghosh, S. (2017) · Immunological Reviews · doi:10.1111/imr.12522 · Cited by 158
Molecular Control of Steady-State Dendritic Cell Maturation and Immune Homeostasis
Hammer, G. E., & Ma, A. I. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074929 · Cited by 158
Luda, K. M., Joeris, T., Persson, E. K., Rivollier, A., Demiri, M., Sitnik, K., Pool, L., Holm, J. B., Melo-González, F., Richter, L., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.008 · Cited by 154
Yewdall, A. W., Drutman, S. B., Jinwala, F., Bahjat, K. S., & Bhardwaj, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011144 · Cited by 152
Imai, T., Kato, Y., Kajiwara, C., Mizukami, S., Ishige, I., Ichiyanagi, T., Hikida, M., Wang, J. O., & Udono, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108372108 · Cited by 150
Virtual-freezing fluorescence imaging flow cytometry
Mikami, H., Kawaguchi, M., Huang, C., Matsumura, H., Sugimura, T., Huang, K., Lei, C., Ueno, S., Miura, T., Ito, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14929-2 · Cited by 148
Wimmers, F., Schreibelt, G., Sköld, A. E., Figdor, C. G., & de Vries, I. J. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00165 · Cited by 149
Antigen Presentation by MHC-Dressed Cells
NAKAYAMA, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00672 · Cited by 152
Control of adaptive immunity by pattern recognition receptors
Carroll, S. L., Pasare, C., & Barton, G. M. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.014 · Cited by 155
Wculek, S. K., Amores, J., Conde‐Garrosa, R., Khouili, S. C., Melero, I., & Sancho, D. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0565-5 · Cited by 145
Self-citationWang, L., Gordon, R. A., Huynh, L., Su, X., Min, K.-H. P., Han, J., Arthur, J. S. C., Kalliolias, G. D., & Ivashkiv, L. B. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.014 · Cited by 144
Tumor-Derived Autophagosome Vaccine: Mechanism of Cross-Presentation and Therapeutic Efficacy
Li, Y., Wang, L., Pang, P., Cui, Z.-H., Aung, S., Haley, D. P., Fox, B. A., Urba, W. J., & Hu, H. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0951 · Cited by 144
Dectin-1/Syk signaling triggers neuroinflammation after ischemic stroke in mice
Ye, X., Qi, H., Ma, W.-J., Zhao, Q., Wang, W., Yin, H., Zhang, T., Wang, M., Zan, K., Yang, X.-X., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1693-z · Cited by 140
Dendritic Cells in Cancer Immunology and Immunotherapy
Hato, L., Atienza, Á. V., Eguren‐Santamaría, I., Perez‐Gracia, J. L., Rodríguez, J., Pérez‐Larraya, J. G., Sarobe, P., Inogés, S., de Cerio, A. L. D., & Santisteban, M. (2024) · Cancers · doi:10.3390/cancers16050981 · Cited by 150
STING, DCs and the link between innate and adaptive tumor immunity
Vatner, R. E., & Janssen, E. M. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.12.001 · Cited by 139
van Dinther, D., Veninga, H., Iborra, S., Borg, E. G. F., Hoogterp, L., Olesek, K., Beijer, M. R., Schetters, S. T. T., Kalay, H., García-Vallejo, J. J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.021 · Cited by 139
Self-citationSignalling C-Type Lectins in Antimicrobial Immunity
Drummond, R. A., & Brown, G. D. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003417 · Cited by 134
Joffre, O. P., Sancho, D., Zelenay, S., Keller, A. M., & Sousa, C. R. E. (2010) · European Journal of Immunology · doi:10.1002/eji.201040419 · Cited by 143
Self-citationPotential of Cyanine Derived Dyes in Photodynamic Therapy
Lange, N., Szlasa, W., Saczko, J., & Chwiłkowska, A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060818 · Cited by 137
Cross-priming in cancer immunology and immunotherapy
Luri‐Rey, C., Teijeira, Á., Wculek, S. K., de Andrea, C. E., Herrero, C., López‐Janeiro, Á., Rodriguez-Ruiz, M. E., Heras‐Murillo, I., Aggelakopoulou, M., Berraondo, P., et al. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-024-00785-5 · Cited by 150
Self-citationBalan, S., Ollion, V., Colletti, N. J., Chelbi, R., Montañana-Sanchis, F., Liu, H., Manh, T. V., Sanchez, C., Savoret, J., Perrot, I., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401243 · Cited by 133
Muzaki, A. R. B. M., Tetlak, P., Sheng, J., Loh, S.-C., Setiagani, Y. A., Poidinger, M., Zolezzi, F., Karjalainen, K., & Ruedl, C. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.64 · Cited by 139
Understanding the Biology of Antigen Cross-Presentation for the Design of Vaccines Against Cancer
Fehres, C. M., Unger, W. W. J., García-Vallejo, J. J., & van Kooyk, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00149 · Cited by 140
Heger, L., Balk, S., Lühr, J. J., Heidkamp, G. F., Lehmann, C. H. K., Hatscher, L., Purbojo, A., Hartmann, A., García‐Martin, F., Nishimura, S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00744 · Cited by 132
Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity
Giampazolias, E., Schulz, O., Lim, K. H. J., Rogers, N. C., Chakravarty, P., Srinivasan, N., Gordon, O., Cardoso, A., Buck, M. D., Poirier, E. Z., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.021 · Cited by 137
Self-citationC-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity
Drouin, M., Coronilla, J. S., & Chiffoleau, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00251 · Cited by 138
Activating systemic autoimmunity: B's, T's, and tolls
Shlomchik, M. J. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.08.005 · Cited by 129
T Cell Zone Resident Macrophages Silently Dispose of Apoptotic Cells in the Lymph Node
Baratin, M., Simon, L., Jorquera, A., Ghigo, C., Dembélé, D., Nowak, J., Gentek, R., Wienert, S., Klauschen, F., MALISSEN, B., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.019 · Cited by 136
The expanding roles of ITAM adapters FcRγ and DAP12 in myeloid cells
Hamerman, J. A., Ni, M., Killebrew, J. R., Chu, C., & Lowell, C. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00841.x · Cited by 133
Grabowska, J. A., Venegas, M. L., Affandi, A. J., & den Haan, J. M. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02472 · Cited by 136
Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies
Iurescia, S., Fioretti, D. P., & Rinaldi, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00711 · Cited by 124
Human mononuclear phagocyte system reunited
Haniffa, M. A., Bigley, V., & Collin, M. P. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.05.004 · Cited by 133
Mysore, V., Culleré, X., Mears, J., Rosetti, F., Okubo, K., Liew, P. X., Zhang, F., Madera-Salcedo, I. K., Rosenbauer, F., Stone, R. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24591-x · Cited by 129
Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1
Thiagarajan, P. S., Yakubenko, V. P., Elsori, D. H., Yadav, S. P., Willard, B. B., Tan, C. D., Rodríguez, E. R., Febbraio, M., & Cathcart, M. K. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt117 · Cited by 126
Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?
Nierkens, S., Tel, J., Janssen, E. M., & Adema, G. J. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.02.007 · Cited by 123
Adaptive immunity after cell death
Zelenay, S., & Sousa, C. R. E. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.03.005 · Cited by 129
Self-citationCancer Immunotherapy via Dendritic Cells
Palucka, K., & Banchereau, J. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4_4 · Cited by 128
Targeting dendritic cells—why bother?
Kreutz, M., Tacken, P. J., & Figdor, C. G. (2013) · Blood · doi:10.1182/blood-2012-09-452078 · Cited by 125
Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and Functions
Manh, T. V., Bertho, N., Hosmalin, A., Schwartz-Cornil, I., & Dalod, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00260 · Cited by 139
Flexible Signaling of Myeloid C-Type Lectin Receptors in Immunity and Inflammation
del Fresno, C., Iborra, S., Saz-Leal, P., Martínez‐López, M., & Sancho, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00804 · Cited by 123
Self-citationEndogenous ligands for C‐type lectin receptors: the true regulators of immune homeostasis
García-Vallejo, J. J., & van Kooyk, Y. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00786.x · Cited by 118
Dendritic cells and cancer immunotherapy
Radford, K. J., Tullett, K. M., & Lahoud, M. H. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.005 · Cited by 120
Cutting Edge: Clec9A+ Dendritic Cells Mediate the Development of Experimental Cerebral Malaria
Piva, L., Tetlak, P., Claser, C., Karjalainen, K., Rénia, L., & Ruedl, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201171 · Cited by 115
T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors
Sey, E. A., Dambuza, I. M., Salazar, F., & Brown, G. D. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.11.007 · Cited by 122
Advances in Therapeutic Cancer Vaccines
Wong, K. K. W., Li, A. W., Mooney, D. J., & Dranoff, G. (2016) · Advances in immunology · doi:10.1016/bs.ai.2015.12.001 · Cited by 115
Contreras, V., Urien, C., Guiton, R., Alexandre, Y. O., Manh, T. V., Andrieu, T., Crozat, K., Jouneau, L., Bertho, N., Epardaud, M., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000824 · Cited by 110
Comparing the effects of different cell death programs in tumor progression and immunotherapy
Messmer, M. N., Snyder, A. G., & Oberst, A. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0214-4 · Cited by 109
CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3
Seillet, C., Jackson, J. T., Markey, K. A., Brady, H. J. M., Hill, G. R., MacDonald, K. P. A., Nutt, S. L., & Belz, G. T. (2013) · Blood · doi:10.1182/blood-2012-07-445650 · Cited by 108
Murshid, A., Gong, J., & Calderwood, S. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903635 · Cited by 108
Calmeiro, J., Carrascal, M. A., Tavares, A. R., Ferreira, D. A., Gomes, C. M. F., Falcão, A. C., Cruz, M. T., & Neves, B. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020158 · Cited by 107
Turning Tumors into Vaccines: Co-opting the Innate Immune System
van den Boorn, J. G., & Hartmann, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.011 · Cited by 106
DNGR-1 in dendritic cells limits tissue damage by dampening neutrophil recruitment
del Fresno, C., Saz-Leal, P., Enamorado, M., Wculek, S. K., Martínez-Cano, S., Blanco-Menéndez, N., Schulz, O., Gallizioli, M., Miró‐Mur, F., Cano, E., et al. (2018) · Science · doi:10.1126/science.aan8423 · Cited by 100
Self-citationThe Role of Necroptosis in ROS-Mediated Cancer Therapies and Its Promising Applications
Hsu, S., Chang, W., Lin, I., Chen, Y., Padalwar, N. B., Cheng, K., Teng, Y., Wang, C., & Chiu, C. (2020) · Cancers · doi:10.3390/cancers12082185 · Cited by 102
Fang, C., Mo, F., Liu, L., Du, J., Luo, M., Men, K., Na, F., Wang, W., Yang, H., & Wei, X. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0456-1 · Cited by 105
Angelot, F., Seillès, E., Biichlé, S., Berda, Y., Gaugler, B., Plumas, J., Chaperot, L., Dignat‐George, F., Tiberghien, P., Saas, P., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.010934 · Cited by 106
Granja, A. G., Leal, E., Pignatelli, J., Castro, R., Abós, B., Kato, G., Fischer, U., & Tafalla, C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500322 · Cited by 97
Wang, H., LeBert, V., Hung, C.-Y., Galles, K., Saijo, S., Lin, X., Cole, G. T., Klein, B. S., & Wüthrich, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302314 · Cited by 99
Iborra, S., Martínez‐López, M., Cueto, F. J., Conde‐Garrosa, R., Fresno, C. D., Izquierdo, H. M., Abram, C. L., Mori, D., Campos‐Martín, Y., Reguera, R. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.012 · Cited by 97
Self-citationCross-Priming Dendritic Cells Exacerbate Immunopathology After Ischemic Tissue Damage in the Heart
Forte, E., Perkins, B., Sintou, A., Kalkat, H., Papanikolaou, A., Jenkins, C., Alsubaie, M., Chowdhury, R. A., Duffy, T. M., Skelly, D. A., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.044581 · Cited by 104
Immunological and Toxinological Responses to Jellyfish Stings
Tibballs, J., Yanagihara, A. A., Turner, H. C., & Winkel, K. D. (2011) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152811797200650 · Cited by 96
Innate immunity as the trigger of systemic autoimmune diseases
Saferding, V., & Blüml, S. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102382 · Cited by 108
Going up in flames: necrotic cell injury and inflammatory diseases
Challa, S., & Chan, F. K.-M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0413-8 · Cited by 100
Metadata
- Authors
- Sancho, D., Joffre, O. P., Keller, A. M., Rogers, N. C., Martínez, D., Hernanz-Falcón, P., Rosewell, I., & Sousa, C. R. E.
- Affiliations
- The Honourable Society of Lincoln's Inn (GB)
- Cancer Research UK (GB)
- Corresponding author
- Sousa, Caetano Reis e
- Venue
- Nature
- Published
- 2009-04
- Volume
- 458
- Issue
- 7240
- Pages
- 899-903
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2671489
- OpenAlex
- W2136883776
- Cited by
- 750
- References
- 27
- Citations by year
- 2026: 17 · 2025: 35 · 2024: 31 · 2023: 44 · 2022: 45 · 2021: 39 · 2020: 44 · 2019: 38 · 2018: 37 · 2017: 30 · 2016: 47 · 2015: 49 · 2014: 54 · 2013: 55 · 2012: 61
- FWCI
- 26.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Cancer Research UK (A3598)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- CLEC9A, DNGR-1, C-type lectin receptors, dendritic cells, CD8α+ dendritic cells, necrosis, cross-presentation, Syk, immunogenicity, tissue repair, inflammation, allograft rejection, tumor rejection
- MeSH terms
- Animals, Cells, Cultured, Dendritic Cells, Humans, Ligands, Necrosis, Phagocytosis, Receptors, Immunologic, Receptors, Mitogen, Signal Transduction, CD8 Antigens, CD8-Positive T-Lymphocytes, Lectins, C-Type, Cross-Priming, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
